Your browser doesn't support javascript.
loading
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity.
Raj, Prithvi; Rai, Ekta; Song, Ran; Khan, Shaheen; Wakeland, Benjamin E; Viswanathan, Kasthuribai; Arana, Carlos; Liang, Chaoying; Zhang, Bo; Dozmorov, Igor; Carr-Johnson, Ferdicia; Mitrovic, Mitja; Wiley, Graham B; Kelly, Jennifer A; Lauwerys, Bernard R; Olsen, Nancy J; Cotsapas, Chris; Garcia, Christine K; Wise, Carol A; Harley, John B; Nath, Swapan K; James, Judith A; Jacob, Chaim O; Tsao, Betty P; Pasare, Chandrashekhar; Karp, David R; Li, Quan Zhen; Gaffney, Patrick M; Wakeland, Edward K.
Affiliation
  • Raj P; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Rai E; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Song R; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India.
  • Khan S; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Wakeland BE; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Viswanathan K; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Arana C; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Liang C; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Zhang B; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Dozmorov I; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Carr-Johnson F; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Mitrovic M; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
  • Wiley GB; Department of Neurology, Yale School of Medicine, New Haven, United States.
  • Kelly JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
  • Lauwerys BR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
  • Olsen NJ; Pole de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium.
  • Cotsapas C; Division of Rheumatology, Department of Medicine, Penn State Medical School, Hershey, United States.
  • Garcia CK; Department of Neurology, Yale School of Medicine, New Haven, United States.
  • Wise CA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States.
  • Harley JB; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, United States.
  • Nath SK; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, United States.
  • James JA; Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, United States.
  • Jacob CO; Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, United States.
  • Tsao BP; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States.
  • Pasare C; Cincinnati VA Medical Center, Cincinnati, United States.
  • Karp DR; Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
  • Li QZ; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
  • Gaffney PM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
  • Wakeland EK; Department of Medicine, University of Southern California, Los Angeles, United States.
Elife ; 52016 Feb 15.
Article in En | MEDLINE | ID: mdl-26880555
ABSTRACT
Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to over 4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / HLA-D Antigens / Autoimmunity / Gene Expression Regulation Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Elife Year: 2016 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / HLA-D Antigens / Autoimmunity / Gene Expression Regulation Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Elife Year: 2016 Type: Article Affiliation country: United States